Primer: Beijing Continent Pharmaceuticals (CPH HK) - Aug 2026
Gyre Therapeutics is a commercial-stage biopharmaceutical company with a strategic focus on developing and commercializing therapies for organ...
89 Views
Pre-IPO Beijing Continent Pharmaceuticals - The Orphan Drug Pioneer Needs to Expand Overseas
Despite promising orphan drug market, with no new drugs commercialized until 2024, Continent will face increasing competition/financial pressure....
688 Views
No more insights